Results 241 to 250 of about 48,074,105 (310)

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Draft genome of <i>Escherichia coli</i> 546 with toxigenic potential, an epizootic important pathogenic isolate obtained from a sick piglet. [PDF]

open access: yesMicrobiol Resour Announc
Tishchenko AS   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy